IVD Raw Materials Industry Presents $35.8 Billion Valuation by 2030 - Expansion of POC and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers ...

The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is projected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report ...
HealthTech

GMP Release and Stability Testing: Ensuring Quality in the Pharmaceutical Sector

GMP release and stability testing are indispensable elements of the pharmaceutical sector’s quality assurance strategy. These testing protocols not only ensure that pharmaceutical products are safe ...
MD&M East

How Early Raw Material Testing Mitigates Product Development & Regulatory Risk

In early medical device product development, analytical testing of raw material commonly is viewed as more of a luxury than a necessity. However, early analytical testing offers medical device ...
News Medical

How do cell therapy manufacturers ensure quality in critical raw materials?

The biopharmaceutical industry has grown remarkably in recent years, with cell and gene therapy (CGT) emerging as a key area amidst continuous technological advancements. As biologics dominate ...
News Medical

Raw material considerations for CGT

This article is based on a poster originally authored by Rebecca Warfield, Yanke Liu, Jane Liu and Spencer Chiang. The responsibility for qualifying GMP or cGMP (current Good Manufacturing Practice) ...